Events & Ideas

Our Work

Prescription Medicines

The 15th Annual Pain Therapeutics Summit

NOVEMBER 1–2, 2021 | WASHINGTON, DC The Potential Role for Psychedelic Drugs in the Treatment of Chronic Pain Psychedelic drugs are currently being evaluated for their efficacy in treating several neuropsychiatric conditions and may have a potential role as treatments for chronic pain. This panel session will explore the potential role that psychedelic drugs… Read More

Prescription Medicines

4th Annual Neuropsychiatric Drug Development Summit

SEPTEMBER 29–30, 2021 | VIRTUAL EVENT Judy Ashworth, MD, Vice President, Rx Strategic Services and Chief Medical Officer, Pinney Associates Clinical & Regulatory Challenges in Developing Psychedelics as Therapeutics Designing clinical trials that meet regulatory requirements without inadvertently stifling market access Managing the impact of CSA Schedule 1 status during development Building an optimal… Read More

Prescription Medicines

Abuse Potential Related Science and Regulatory Perspectives for Psychedelic Drug Product Development

Jack Henningfield, PhD, Vice President, Research, Health Policy, and Abuse Liability, Pinney Associates Presented as part of the NIH Psilocybin Speaker Series, April 22-June 10, 2021 VISIT THE SPEAKER SERIES WEBSITE

Prescription Medicines

Design and Operational Challenges in Psychedelic Clinical Trials

Marion Coe, PhD, Director, Clinical Development and Postmarketing Surveillance, Pinney Associates Presented as part of the session Hot Topics in Psychedelic Drug Development: From Successful Clinical Trials to Maximizing Benefits in the Post-approval World, May 5, 2021 VISIT THE CONFERENCE WEBSITE